ICD code definitions

CPT® Code 84681: C-Peptide

October 30, 2026
•
3 min read
CPT® Code 84681

CPT® Code 84681 is used to report laboratory testing for C-peptide, a substance released when the pancreas produces insulin. Measuring C-peptide can help assess endogenous insulin production and support evaluation of diabetes and related metabolic conditions.

Key Facts About CPT® Code 84681

  • Service type: Laboratory testing ‍
  • Test: C-peptide ‍
  • Purpose: Assess endogenous insulin production ‍
  • Specimen: Typically blood, according to laboratory requirements ‍
  • Common specialties: Endocrinology, primary care, internal medicine ‍
  • Provider type: Physician or qualified healthcare professional; testing performed by a clinical laboratory
Common clinical uses:
  • Evaluation of insulin production
  • Assessment of diabetes type or classification
  • Evaluation of hypoglycemia
  • Assessment of pancreatic beta-cell function
  • Monitoring endogenous insulin production in selected patients

When to Use CPT® 84681

CPT 84681 may be reported when C-peptide testing is medically necessary to evaluate endogenous insulin production.

Examples:
  • A clinician evaluates whether a patient is producing endogenous insulin
  • C-peptide testing is used as part of a diabetes classification assessment
  • A patient with unexplained hypoglycemia undergoes evaluation of insulin production

Interpretation should consider the patient's glucose level, clinical history, and other relevant laboratory findings.

Documentation Requirements

Documentation supporting CPT 84681 should include:

  • Patient identifiers and date of service
  • Clinical indication for testing
  • Relevant symptoms or diagnoses
  • C-peptide test ordered or performed
  • Laboratory result
  • Relevant concurrent glucose information when clinically applicable
  • Clinical interpretation when appropriate
  • Provider authentication

The record should demonstrate the medical necessity of the C-peptide test.

Reimbursement and Coding Considerations

  • CPT 84681 represents C-peptide testing
  • Coverage and medical-necessity requirements vary by payer
  • Additional glucose, insulin, or metabolic testing may be separately reportable when medically necessary and appropriately coded
  • Practices should verify payer-specific policies before submitting claims
  • Laboratory specimen and testing requirements should be followed

Clear documentation of the reason for testing and the resulting laboratory findings helps support appropriate coding and reimbursement.

How OptiMantra Supports Laboratory Documentation

OptiMantra helps practices document laboratory orders, results, diagnoses, and treatment plans within the patient's medical record.

With OptiMantra, providers can:

  • Document indications for C-peptide testing
  • Record C-peptide and related laboratory results
  • Review laboratory findings within the patient chart
  • Link laboratory findings to diagnoses and treatment plans
  • Use customizable chart templates for consistent documentation

Try OptiMantra for free here!

Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.

‍

Jessica Castro
Jessica Castro

Jessica is a Massachusetts-based LPN with 13+ years of experience in patient care, healthcare technology, and education. As the Implementation and Customer Success Manager at OptiMantra, she helps providers optimize EMR solutions for better workflows and patient outcomes. With a Bachelor's in Community Health and a Master's in Healthcare Innovation in progress, she is passionate about leveraging technology to improve care delivery. Through her writing, she shares insights on healthcare best practices, EHR optimization, and patient advocacy to support providers in delivering exceptional care.